# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 136: Amendment of regulation 169 (mixing of general sale medicinal products)

Extent: E+W+S+N.I.

In regulation 169(9)(a), for “marketing authorisation” substitute “UK marketing authorisation or EU marketing authorisation” .

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/136 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-136
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.